Apellis Pharmaceuticals

We deeply care about the needs of people living with debilitating retinal diseases. We're proud to support Prevent Blindness in their mission to reduce barriers to care and advance meaningful policy, research and programs in eye health. #WeAreApellis

We’re excited to share that 6 abstracts, including 5 oral presentations, will be presented at the American Society of Retina Specialists (ASRS) Annual Scientific Meeting July 17 - 20 in Stockholm, Sweeden: https://bit.ly/3XVMthv These data include a late-breaking presentation showing our #GeographicAtrophy (GA) treatment demonstrated visual function benefit on prespecified endpoint in the GALE long-term extension study. #ASRS2024

Today, we shared a regulatory update on the review of our investigational treatment for geographic atrophy in the European Union. Learn more: https://bit.ly/45G0nGB

What a night! We joined the BrightFocus Foundation last night for Concert For Cures, which supports patients living with retina diseases. Thank you BrightFocus Foundation for a night of hope, innovation and music! #WeAreApellis

The challenge is on. We’re looking for an #ApellisEyeQ champion - check out this week’s poll! #WeAreApellis

We strive to understand the unique challenges people with rare diseases face and are committed to always putting patients first. We take pride in supporting patients like Ashley, who is living with #PNH, a rare and potentially life-threatening blood disease. Learn more about our commitment to the rare disease community: https://bit.ly/4baXFv2 #WeAreApellis

At Apellis, each of our values guide every decision we make as we strive toward our vision of being known for our compassion, revolutionary science, and contributions to humankind around the world. #WeAreApellis Learn more about our culture: https://lnkd.in/ezckD-Ns

We were thrilled to join the National Organization for Rare Disorders and members of the rare disease community to tackle critical issues facing patients and caregivers at the #LivingRareSummit. Thank you #NORD and Jill Pollander for such an inspiring event! #WeAreApellis

#TeamApellis had a ball at Bio-Ball 2024 last week! 🏀 We were honored to support this event and its mission to fund inclusive experiences for more than 19,000 Special Olympics athletes in Massachusetts. #WeAreApellis #WeCare

This weekend, we shared that our #GeographicAtrophy (GA) treatment preserved visual function at 36 months in the GALE long-term extension study: https://bit.ly/3VAYreU These important data were presented at the Clinical Trials at the Summit Meeting on Saturday. #CTSRetina2024